pd 98059 has been researched along with norleucine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berrou, J; Berthier, C; Boulanger, E; Hertig, A; Marti, HP; Mauviel, A; Rondeau, E; Tostivint, I; Verrecchia, F; Wautier, JL; Wautier, MP | 1 |
1 other study(ies) available for pd 98059 and norleucine
Article | Year |
---|---|
Advanced glycation end products regulate extracellular matrix protein and protease expression by human glomerular mesangial cells.
Topics: alpha-Macroglobulins; Antibodies; Blotting, Northern; Cells, Cultured; Enzyme-Linked Immunosorbent Assay; Extracellular Matrix Proteins; Flavonoids; Flow Cytometry; Gene Expression; Glycation End Products, Advanced; Humans; Lysine; Matrix Metalloproteinase 2; Mesangial Cells; Norleucine; Oligonucleotide Array Sequence Analysis; Plasminogen Activator Inhibitor 1; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Reverse Transcriptase Polymerase Chain Reaction; Tissue Inhibitor of Metalloproteinase-3; Tissue Plasminogen Activator | 2009 |